ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 156 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,533 | -47.8% | 2,823 | 0.0% | 0.00% | – |
| Q2 2023 | $60,412 | -47.1% | 2,823 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $114,162 | -21.9% | 2,823 | -10.2% | 0.00% | 0.0% |
| Q4 2022 | $146,166 | -12.5% | 3,142 | -2.1% | 0.00% | 0.0% |
| Q3 2022 | $167,000 | +9.9% | 3,210 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $152,000 | -34.2% | 3,210 | -0.9% | 0.00% | 0.0% |
| Q1 2022 | $231,000 | +9.5% | 3,240 | +14.8% | 0.00% | 0.0% |
| Q4 2021 | $211,000 | +31.9% | 2,823 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $160,000 | +29.0% | 2,823 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $124,000 | -10.8% | 2,823 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $139,000 | +16.8% | 2,823 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $119,000 | -7.8% | 2,823 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $129,000 | -9.2% | 2,823 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $142,000 | +163.0% | 2,823 | +168.6% | 0.00% | 0.0% |
| Q1 2020 | $54,000 | -16.9% | 1,051 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $65,000 | +51.2% | 1,051 | +48.0% | 0.00% | – |
| Q3 2019 | $43,000 | -28.3% | 710 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $60,000 | -11.8% | 710 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $68,000 | +41.7% | 710 | +4.7% | 0.00% | – |
| Q4 2018 | $48,000 | -17.2% | 678 | 0.0% | 0.00% | – |
| Q3 2018 | $58,000 | -9.4% | 678 | +23.5% | 0.00% | -100.0% |
| Q2 2018 | $64,000 | +45.5% | 549 | 0.0% | 0.00% | – |
| Q1 2018 | $44,000 | +37.5% | 549 | 0.0% | 0.00% | – |
| Q4 2017 | $32,000 | +23.1% | 549 | 0.0% | 0.00% | – |
| Q3 2017 | $26,000 | +30.0% | 549 | 0.0% | 0.00% | – |
| Q2 2017 | $20,000 | +185.7% | 549 | +133.6% | 0.00% | – |
| Q1 2017 | $7,000 | -12.5% | 235 | 0.0% | 0.00% | – |
| Q4 2016 | $8,000 | +33.3% | 235 | 0.0% | 0.00% | – |
| Q3 2016 | $6,000 | +20.0% | 235 | 0.0% | 0.00% | – |
| Q2 2016 | $5,000 | -28.6% | 235 | 0.0% | 0.00% | – |
| Q1 2016 | $7,000 | -12.5% | 235 | 0.0% | 0.00% | – |
| Q4 2015 | $8,000 | 0.0% | 235 | 0.0% | 0.00% | – |
| Q3 2015 | $8,000 | -27.3% | 235 | 0.0% | 0.00% | – |
| Q2 2015 | $11,000 | +57.1% | 235 | 0.0% | 0.00% | – |
| Q1 2015 | $7,000 | – | 235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |